{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T15:54:00Z","timestamp":1648914840030},"reference-count":139,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.ncl.2004.04.001","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T14:53:34Z","timestamp":1113836014000},"page":"703-717","source":"Crossref","is-referenced-by-count":2,"title":["Autoantibody testing"],"prefix":"10.1016","volume":"22","author":[{"given":"Rahman","family":"Pourmand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2004.04.001_BIB1","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/(SICI)1097-4598(199710)20:10<1275::AID-MUS10>3.0.CO;2-2","article-title":"Antibody panels in idiopathic polyneuropathies and motor neuron disease","volume":"20","author":"Wolfe","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2004.04.001_BIB2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00002281-200011000-00001","article-title":"Update on myositis-specific and myositis-associated autoantibodies","volume":"12","author":"Targoff","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00131402-200009000-00010","article-title":"Myositis-specific and associated autoantibodies: a review from the clinical perspective","volume":"2","author":"Lacomis","year":"2000","journal-title":"J Clin Neuromusc Dis"},{"key":"10.1016\/j.ncl.2004.04.001_BIB4","series-title":"Diagnosis and management of peripheral nerve disorders (CNS)","first-page":"67","article-title":"The role of autoantibody testing","author":"Kissel","year":"2001"},{"key":"10.1016\/j.ncl.2004.04.001_BIB5","series-title":"Clinical evaluation and diagnostic tests for neuromuscular disorders","first-page":"99","article-title":"Autoantibody testing","author":"Narayanaswami","year":"2002"},{"key":"10.1016\/j.ncl.2004.04.001_BIB6","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.55.10.1531","article-title":"The clinical spectrum of anti-GAD antibody positive patient with stiff-person syndrome","volume":"55","author":"Dalakas","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB7","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1212\/WNL.57.5.780","article-title":"Stiff-person syndrome. Quantification, specificity and intrathecal synthesis of GAD65 antibodies","volume":"57","author":"Dalakas","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00936885","article-title":"Stiff-man syndrome: neurophysiologic finding in eight patients","volume":"242","author":"Meinck","year":"1995","journal-title":"J Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(88)92328-8","article-title":"Autoimmunity in stiff-man syndrome","volume":"2","author":"Williams","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2004.04.001_BIB10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0166-2236(91)90044-U","article-title":"Autoimmunity of glutamic acid decarboxylase (GAD) in stiff-man syndrome and insulin dependent diabetes mellitus","volume":"14","author":"Solimena","year":"1991","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.ncl.2004.04.001_BIB11","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s004150050425","article-title":"The stiff-man and stiff-man plus syndrome","volume":"246","author":"Brown","year":"1999","journal-title":"J Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB12","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.4065\/73.12.1161","article-title":"Radioimmunoassay for glutamic acid decarboxylase (GDA65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate susceptibility to type 1 diabetes mellitus","volume":"73","author":"Walikonis","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ncl.2004.04.001_BIB13","doi-asserted-by":"crossref","first-page":"522","DOI":"10.7326\/0003-4819-131-7-199910050-00008","article-title":"The stiff-person syndrome: an autoimmune disorder affecting gamma aminobutyric acid","volume":"131","author":"Levy","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ncl.2004.04.001_BIB14","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJM198804213181602","article-title":"Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy and type 1 diabetes mellitus","volume":"318","author":"Solimena","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ncl.2004.04.001_BIB15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jnnp.62.4.395","article-title":"Antibodies to 125I - glutamic acid decarboxylase in patients with stiff-man syndrome","volume":"62","author":"Vincent","year":"1997","journal-title":"J Neurol Psychiatry"},{"key":"10.1016\/j.ncl.2004.04.001_BIB16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nm0296-148","article-title":"The clinical significance of an autoimmune response against glutamic acid decarboyxlase","volume":"2","author":"Ellis","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.ncl.2004.04.001_BIB17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/BF03347745","article-title":"GAD, diabetes and stiff-man syndrome: some progress and more questions","volume":"17","author":"Solimena","year":"1994","journal-title":"J Endocrinal Invest"},{"key":"10.1016\/j.ncl.2004.04.001_BIB18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJM199302253280805","article-title":"Autoantibodies to a 128-kd synaptic protein in three women with stiff-man syndrome and breast cancer","volume":"328","author":"Folli","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ncl.2004.04.001_BIB19","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1084\/jem.178.6.2219","article-title":"The synoptic vesicle-associated protein amphiphysin is the 128-kd autoantigen of stiff-man syndrome with breast cancer","volume":"178","author":"DeCamilli","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.ncl.2004.04.001_BIB20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/jnnp.66.2.214","article-title":"Anti-amphiphysin 1 antibodies in patients with paraneoplastic neurologic disorders associated with small cell lung carcinoma","volume":"66","author":"Saiz","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2004.04.001_BIB21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1212\/01.WNL.0000073143.53337.DD","article-title":"Neuropathology and binding studies in anti-amphiphysin associated with stiff-person syndrome","volume":"61","author":"Weissig","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.7326\/0003-4819-131-7-199910050-00008","article-title":"Autoantibodies and immunopathogenesis of the stiff-person syndrome. In Levy LM (moderator). The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of V-aminobutyric acid","volume":"131","author":"Dalakas","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ncl.2004.04.001_BIB23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.410440209","article-title":"Inhibition of gamma aminobutyric acid synthesis by glutamic acid decarboxylase antoantibodies in stiff-man syndrome","volume":"44","author":"Dinkel","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archneur.61.1.44","article-title":"Idiopathic autoimmune neuropathy. Comparison seropositive and seronegative for ganglionic acetylcholine receptor antibody","volume":"61","author":"Sandroni","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB25","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1212\/WNL.50.6.1806","article-title":"Neuronal nicotinic AChR antibody in subacute autonomic neuropathy and cancer related syndrome","volume":"50","author":"Vernino","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM200009213431204","article-title":"Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies","volume":"343","author":"Vernino","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ncl.2004.04.001_BIB27","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ana.10556","article-title":"The spectrum of autoimmune autonomic neuropathies","volume":"53","author":"Klein","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB28","series-title":"Arthritis and allied conditions: a textbook of rheumatology","first-page":"1736","article-title":"Sjogren's syndrome","author":"Jansson","year":"2001"},{"key":"10.1016\/j.ncl.2004.04.001_BIB29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0030-6665(03)00024-0","article-title":"Sjogren's disease","volume":"36","author":"Mahoney","year":"2003","journal-title":"Otolarngol Clin North Am"},{"key":"10.1016\/j.ncl.2004.04.001_BIB30","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"The European study group on classification criteria for Sjogren's syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ncl.2004.04.001_BIB31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0733-8619(03)00057-4","article-title":"Neurologic manifestations of connective tissue disease","volume":"20","author":"Nadeau","year":"2002","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ncl.2004.04.001_BIB32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/030097400447525","article-title":"Current conception diagnosis, antoantibodies and therapy iin Sjogren's syndrome","volume":"29","author":"Jansson","year":"2000","journal-title":"Scan J Rheumatol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00019052-199710000-00002","article-title":"Autoimmune ataxic sensory neuronopathy","volume":"10","author":"O'Leray","year":"1997","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0733-8619(03)00055-0","article-title":"Remote neurologic manifestations of cancer","volume":"20","author":"Dropcho","year":"2002","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ncl.2004.04.001_BIB35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0733-8619(02)00037-3","article-title":"Paraneoplastic neurologic syndrome","volume":"21","author":"Bataller","year":"2003","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ncl.2004.04.001_BIB36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1474-4422(02)00135-7","article-title":"Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis and therapy","volume":"1","author":"Voltz","year":"2002","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB37","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/(SICI)1097-4598(199612)19:12<1517::AID-MUS1>3.0.CO;2-D","article-title":"AAEM case report #31. Paraneoplastic sensory neuronopathy","volume":"19","author":"Pourmand","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2004.04.001_BIB38","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/brain\/awf006","article-title":"Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients","volume":"125","author":"Camdessandre","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2004.04.001_BIB39","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","article-title":"Anti Hu associated paraneoplastic encephalomyelitis: analysis of 200 patients","volume":"24","author":"Graurs","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2004.04.001_BIB40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/1531-8249(200007)48:1<105::AID-ANA16>3.0.CO;2-G","article-title":"Fluoro-deoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti Hu antibodies","volume":"48","author":"Antoine","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archneur.61.1.30","article-title":"Paraneoplastic neurologic disorders: windows to neuronal function and tumor immunity","volume":"61","author":"Darnell","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1600-0404.1999.tb00387.x","article-title":"Anti neuronal antibodies in serum and cerebrospinal gluid of amyotrophic lateral sclerosis (ALS) patients","volume":"100","author":"Neibroj-Dobosz","year":"1999","journal-title":"Act Neuro Scand"},{"key":"10.1016\/j.ncl.2004.04.001_BIB43","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ana.410250118","article-title":"Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis","volume":"25","author":"Pestronk","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1351-5101.2003.00697.x","article-title":"Serum IgM anti GM1 ganglioside antibodies in lower motor neuron syndrome","volume":"11","author":"Niebroj-Dobosz","year":"2004","journal-title":"Eur J Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.ncl.2004.04.001_BIB45","first-page":"543","article-title":"Chronic motor neuropathies: diagnosis, therapy and pathogenesis","volume":"32","author":"Kornberg","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB46","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ana.410390417","article-title":"Anti GD1a ganglioside antibodies in peripheral motor syndromes","volume":"39","author":"Carpo","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB47","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/mus.880160610","article-title":"Association of Ig6 with anti GD1a antibody with severe Guillain Barre syndrome","author":"Yuki","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2004.04.001_BIB48","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.410350510","article-title":"N-Acetylgalacto-saminyl Gd1a is target molecule for serum antibody in Guillain Barre syndrome","volume":"35","author":"Kusunoki","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00315684","article-title":"Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulfatide of peripheral nerve myelin","volume":"238","author":"Fredman","year":"1991","journal-title":"J Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB50","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1212\/01.WNL.0000061615.77865.83","article-title":"Gani GM1 antibody IgG subclass. A clinical recovery predictor in Guillain Barre syndrome","volume":"60","author":"Koga","year":"2003","journal-title":"Neurolgy"},{"key":"10.1016\/j.ncl.2004.04.001_BIB51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ana.410410302","article-title":"Changing views of Guillain Barre syndrome","volume":"41","author":"Asbury","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB52","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1086\/314725","article-title":"Ganglioside GM1 mimicry in Campylobacter strain from sporadic infections in the United States","volume":"179","author":"Nachamkin","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ncl.2004.04.001_BIB53","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1212\/WNL.40.12.1900","article-title":"Acute axonal polyneuropathy associated with anti GM1 antibodies following Campylobacter enteritis","volume":"40","author":"Yuki","year":"1990","journal-title":"Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB54","first-page":"6","article-title":"Anti GM antibodies in patients with Guillain Barre syndrome","volume":"55","author":"Van Den Berg","year":"1992","journal-title":"J Neurol Neurosurg Psychiary"},{"key":"10.1016\/j.ncl.2004.04.001_BIB55","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","article-title":"Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China","volume":"33","author":"McKhann","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB56","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ana.410380516","article-title":"Anti ganglioside GM1 antibodies in Giullain Barre syndrome and their relationship to Campylobacter jejuni infection","volume":"38","author":"Rees","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.410400209","article-title":"Campylobacter jejuni infections and anti GM1 antibodies in Guillain Barre syndrome","volume":"40","author":"Jacolis","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB58","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ana.410350610","article-title":"Monoclonal IgM antibodies to GM1 and asialo-GM in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides","volume":"35","author":"Wirguin","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB59","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6","article-title":"Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain Barre syndrome","volume":"45","author":"Ho","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB60","series-title":"Neuromuscular diseases. expert clinician's views. Immune mediated neuropathies","first-page":"135","author":"Saperstein","year":"2001"},{"key":"10.1016\/j.ncl.2004.04.001_BIB61","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1128\/IAI.62.5.2101-2103.1994","article-title":"Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1a epitope","volume":"62","author":"Yuki","year":"1994","journal-title":"Infect Immunol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB62","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.56.8.1104","article-title":"Clinical features and prognosis of Miller Fisher syndrome","volume":"56","author":"Mori","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB63","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/jnnp.40.8.801","article-title":"Peripheral nerve conduction in Miller Fisher syndrome","volume":"40","author":"Guiloff","year":"1997","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"10.1016\/j.ncl.2004.04.001_BIB64","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/(SICI)1097-4598(199802)21:2<239::AID-MUS13>3.0.CO;2-X","article-title":"Ophthalmoplegia and lower cranial nerve variant merge into each other and into classical Gullian Barre syndrome","volume":"21","author":"Ter Bruggen","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2004.04.001_BIB65","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1212\/WNL.43.10.1911","article-title":"Serum anti GQ1b associated with ophthalmoplegia in Miller Fisher syndrome and Guillain Barre syndrome: clinical and immunohistochemical studies","volume":"43","author":"Chiba","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB66","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp.56.2.204","article-title":"Miller-Fisher syndrome is associated with serum antibodies to GQ-1b ganglioside","volume":"56","author":"Willison","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2004.04.001_BIB67","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/1531-8249(199902)45:2<189::AID-ANA9>3.0.CO;2-T","article-title":"Miller Fisher anti GQ1b antibodies: a latrotoxin-like effect on motor endplate","volume":"45","author":"Plomp","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB68","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1212\/WNL.56.1.67","article-title":"Combined pre-and post-synaptic action of IgG in Miller-Fisher syndrome","volume":"56","author":"Buchwald","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB69","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF00868348","article-title":"High dose immunoglobulin therapy is effective in Miller Fisher syndrome","volume":"241","author":"Zifkon","year":"1994","journal-title":"J Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB70","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","article-title":"Clinical spectrum of chronic acquired demyelinating polyneuropathies","volume":"24","author":"Saperstein","year":"2001","journal-title":"Muscle Nerve"},{"issue":"Suppl 6","key":"10.1016\/j.ncl.2004.04.001_BIB71","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.59.12_suppl_6.S2","article-title":"Diagnosis of CIDP","volume":"59","author":"Latov","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB72","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-5728(96)00189-0","article-title":"Immunological investigations of chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Melendez-Vasquez","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB73","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/brain\/117.5.949","article-title":"The natural history of chronic demyelinating neuropathy associated with IgM paraproteinemia. A clinical and neurophysiological study","volume":"117","author":"Smith","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2004.04.001_BIB74","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/mus.880111111","article-title":"Demyelination induced by intraneural injection of human anti-myelin associated glycoprotein antibodies","volume":"11","author":"Willison","year":"1988","journal-title":"Muscle Nerve"},{"issue":"Suppl 3","key":"10.1016\/j.ncl.2004.04.001_BIB75","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1212\/WNL.60.8_suppl_3.S8","article-title":"Research criteria for defining patients with CIDP","volume":"60","author":"Sander","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB76","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-2003-814745","article-title":"Multifocal motor neuropathy with conduction block. Current issues in diagnosis and treatment","volume":"23","author":"Nagale","year":"2003","journal-title":"Semin Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB77","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00415-003-1068-2","article-title":"Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients","volume":"250","author":"Busby","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB78","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<900::AID-MUS9>3.0.CO;2-Y","article-title":"Natural history of 46 patients with multifocal motor neuropathy with conduction block","volume":"23","author":"Taylor","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2004.04.001_BIB79","doi-asserted-by":"crossref","unstructured":"Katz JS, Wolfe GI, Bryan WW, et al. Electrophysiologic findings in multifocal motor neuropathy. Neurology 197;48:700\u20137.","DOI":"10.1212\/WNL.48.3.700"},{"key":"10.1016\/j.ncl.2004.04.001_BIB80","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/(SICI)1097-4598(199802)21:2<243::AID-MUS14>3.0.CO;2-2","article-title":"Multifocal motor neuropathy without overt conduction block","volume":"21","author":"Pakiam","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2004.04.001_BIB81","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1212\/WNL.58.4.615","article-title":"Axonal multifocal motor neuropathy without conductin block or other features of demyelination","volume":"58","author":"Katz","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB82","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-5728(91)90192-A","article-title":"Predictive value of anti-GM1 ganglioside antibodies in neuromuscular disease: a study of 180 sera","volume":"32","author":"Adams","year":"1991","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB83","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1749-6632.1998.tb09684.x","article-title":"Antiglycolipid antibodies in motor neuropathies","volume":"845","author":"Baumann","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ncl.2004.04.001_BIB84","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1212\/WNL.47.4.951","article-title":"The sensitivity and specificity of anti GM1 antibody testing","volume":"47","author":"Taylor","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB85","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1212\/WNL.49.5.1289","article-title":"Multifocal motor neuropathy: serum IgM anti-GM1 ganglioside in most patients detected using covalent linked-age of GM1 to ELISA plates","volume":"49","author":"Pestronk","year":"1997","journal-title":"Neurology"},{"issue":"6 Suppl 5","key":"10.1016\/j.ncl.2004.04.001_BIB86","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1212\/WNL.51.6_Suppl_5.S22","article-title":"Multifocal motor neuropathy: diagnosis and treatment","volume":"51","author":"Pestronk","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB87","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF00319857","article-title":"The clinical spectrum of peripheral neuropathy associated with benign monoclonal IgM, IgG and IgA paraproteinemia: comparative clinical, immunological and nerve biopsy findings","volume":"238","author":"Yeung","year":"1991","journal-title":"J Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB88","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0960-8966(95)00021-6","article-title":"Neuropathies associated with monoclonal gammopathies","volume":"6","author":"Kissel","year":"1996","journal-title":"Neuromuscl Disord"},{"key":"10.1016\/j.ncl.2004.04.001_BIB89","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1212\/WNL.36.1.75","article-title":"Monoclonal gammopathy and neuropathy: myelin associated glycoprotein reactivity and clinical characteristics","volume":"36","author":"Hafler","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB90","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ana.410360313","article-title":"Frequency and clinical correlates of anti-neuronal IgM antibodies in neuropathy associated with IgM monoclonal gammopathy","volume":"36","author":"Nobile-Orazio","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB91","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/jnnp.61.1.36","article-title":"Chronic immune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients","volume":"61","author":"Maisonobe","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2004.04.001_BIB92","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/(SICI)1097-4598(199605)19:5<637::AID-MUS12>3.0.CO;2-K","article-title":"Anti-MAG and anti-SGPG antibodies in neuropathy","volume":"19","author":"Van den Berg","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2004.04.001_BIB93","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/brain\/117.6.1385","article-title":"Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities","volume":"117","author":"Notermans","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2004.04.001_BIB94","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/mus.880180709","article-title":"Motor conduction in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies","volume":"18","author":"Trojaborg","year":"1995","journal-title":"Mucle Nerve"},{"key":"10.1016\/j.ncl.2004.04.001_BIB95","first-page":"301","article-title":"Peripheral neuropathy and anti-MAG antibody","volume":"3","author":"Latov","year":"1988","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB96","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0165-5728(93)90077-C","article-title":"Antibodies to sulfatide and chrondroitin sulfate C in patients with chronic sensory","volume":"43","author":"Nemni","year":"1993","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB97","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1136\/jnnp.56.11.1164","article-title":"Anti-sulfatide antibodies in peripheral neuropathy","volume":"56","author":"Van den Berg","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2004.04.001_BIB98","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/jnnp.62.6.581","article-title":"Polyneuropathies associated with high titer antisulfatide antibodies: characteristics of patients with and without serum monoclonal proteins","volume":"62","author":"Lopate","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2004.04.001_BIB99","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1212\/WNL.54.7.1448","article-title":"Antisulfatide antibodies in neuropathy: clinical and electrophysiologic correlate","volume":"54","author":"Dabby","year":"2000","journal-title":"Nuerology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB100","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/awf178","article-title":"Phenotypic variants of autoimmune peripheral nerve hyperexcitability","volume":"125","author":"Hart","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2004.04.001_BIB101","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/mus.1078","article-title":"Acquired neuromyotonia and peripheral neuropathy in a patient with Hodgkin's disease","volume":"24","author":"Lahmann","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2004.04.001_BIB102","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/(SICI)1097-4598(200005)23:5<655::AID-MUS1>3.0.CO;2-E","article-title":"Understanding neuromyotonia","volume":"23","author":"Vincent","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2004.04.001_BIB103","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0733-8619(01)00005-6","article-title":"Needle electromyography: Fundamentals, normal and abnormal patterns","volume":"20","author":"Preston","year":"2002","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ncl.2004.04.001_BIB104","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00000441-200004000-00003","article-title":"Acquired neuromyotoia: a new antibody mediated neuronal potassium channelopathy","volume":"319","author":"Hart","year":"2002","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ncl.2004.04.001_BIB105","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ana.410410215","article-title":"Autoantibodies detected to expressed K+channels are implicated in neuromyotonia","volume":"41","author":"Hart","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB106","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410380505","article-title":"Acquired neuromyotonia. Evidence for autoantibodies dircted against K+channels of peripheral nerve","volume":"38","author":"Shillito","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB107","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1568-9972(02)00146-5","article-title":"Autoantibodies to ion channels at the neuromuscular junction","volume":"2","author":"Lang","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ncl.2004.04.001_BIB108","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1196\/annals.1254.022","article-title":"Autoimmune disorders of neuronal potassium channels","volume":"998","author":"Newsom-Davis","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 11","key":"10.1016\/j.ncl.2004.04.001_BIB109","first-page":"S55","article-title":"Isacc's syndrome as a potassium channelopathy of the nerve","author":"Arimura","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2004.04.001_BIB110","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/mus.10266","article-title":"Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability","volume":"26","author":"Vernino","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2004.04.001_BIB111","series-title":"Neuromuscular diseases: expert clinician's view","first-page":"439","article-title":"Myasthenia gravis and Lambert-Eaton myasthenic syndrome","author":"Sanders","year":"2001"},{"key":"10.1016\/j.ncl.2004.04.001_BIB112","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO;2-O","article-title":"Acetycholine receptors and myasthenia","volume":"23","author":"Lindstrom","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2004.04.001_BIB113","unstructured":"Sanders DB, Howard JF, Massey JM. Acetycholine receptor antibody determinants in 724 patients with acquired masthenia gravis (MG). Presented at the Annual Scientific Session, Myasthenia Gravis Foundation of America, 1992."},{"key":"10.1016\/j.ncl.2004.04.001_BIB114","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1749-6632.1987.tb51321.x","article-title":"Clinical correlations of antibodies that binds block or modulate human acetylcholine receptors in myasthenia gravis","volume":"505","author":"Howard","year":"1987","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 5","key":"10.1016\/j.ncl.2004.04.001_BIB115","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1212\/WNL.48.Suppl_5.40S","article-title":"Seronegative myasthenia gravis","volume":"48","author":"Sanders","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB116","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1474-4422(03)00306-5","article-title":"Seronegative gerneralized myasthenia gravis: Clinical features, antibodies and their target","volume":"2","author":"Vincent","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB117","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1212\/WNL.41.4.520","article-title":"Diagnosis of thymoma in myasthenia gravis using anti-striated muscle receptor antibodies in myasthenia gravis","volume":"41","author":"Lanska","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB118","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1212\/WNL.43.8.1581","article-title":"Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin","volume":"43","author":"Gautel","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB119","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1212\/WNL.59.1.92","article-title":"The occurrence of anti-titin antibodies and thymomas. A population survey of MG 1970\u20131999","volume":"59","author":"Somnier","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB120","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1212\/WNL.57.9.1579","article-title":"Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?","volume":"57","author":"Buckley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB121","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archneur.57.4.527","article-title":"Autoantobodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia","volume":"57","author":"Mygland","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB122","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Autoantibodies to the receptor tyrosine kinase, MUSK in patients with myasthenia gravis without acetylcholine receptor antibody","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.ncl.2004.04.001_BIB123","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/01.WNL.0000041625.41937.FF","article-title":"AChR phosphorylation and indirect inhibition of AChR function in seronegative MG","volume":"59","author":"Plested","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB124","doi-asserted-by":"crossref","first-page":"3240335","DOI":"10.1196\/annals.1254.036","article-title":"Autoantibodies in myasthenia and related disorders","volume":"998","author":"Vincent","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ncl.2004.04.001_BIB125","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical aspects of MUSK antibody positive seronegative MG","volume":"60","author":"Sanders","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB126","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MUSK antobodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2004.04.001_BIB127","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.WNL.0000041026.90947.79","article-title":"What's in the serum of seronegative MG and LEMS. MUSK et al","volume":"59","author":"Abicht","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB128","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/111.3.577","article-title":"The Lambert-Eaton myasthenic syndrome: a review of 50 cases","volume":"111","author":"O'Neill","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2004.04.001_BIB129","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM199506013322203","article-title":"Calcium channel antibodies in Lambert-Eaton myasthenic syndrome and other paraneoplastic syndrome","volume":"332","author":"Lennon","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ncl.2004.04.001_BIB130","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1749-6632.1998.tb10992.x","article-title":"The role of autoantibodies in Lambert-Eaton myasthenic syndrome","volume":"841","author":"Lang","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ncl.2004.04.001_BIB131","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/(SICI)1097-4598(199901)22:1<119::AID-MUS19>3.0.CO;2-5","article-title":"P\/Q-type voltage-gate calcium channel antibodies in paraneoplastic disorders of the central nervous system","volume":"22","author":"Voltz","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2004.04.001_BIB132","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11940-001-0047-0","article-title":"Lambert-Eaton myasthenic syndrome","volume":"3","author":"Newsom-Davis","year":"2001","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB133","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1196\/annals.1254.019","article-title":"Pathogenic autoantibodies in the Lambert-Eaton myasthenic syndrome","volume":"998","author":"Lang","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ncl.2004.04.001_BIB134","first-page":"475","article-title":"Seronegative Lambert-Eaton myasthenic syndrome. Study of 110 Japanese patients","volume":"12","author":"Nakao","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2004.04.001_BIB135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00000441-200004000-00005","article-title":"Autoantibodies in inflammatory myopathies","volume":"319","author":"Garlepp","year":"2000","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ncl.2004.04.001_BIB136","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00002281-200111000-00004","article-title":"Myositis-specific autoantibodies: overview and recent development","volume":"13","author":"Hengstman","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB137","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/PL00007850","article-title":"Clinical and serological characteristics of 125 Dutch myositis patients","volume":"249","author":"Hengstman","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB138","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.1780351014","article-title":"Serum Autoantibodies to nucleolar antigen PM-Scl: Clinical and immunogenic associations","volume":"35","author":"Oddis","year":"1992","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ncl.2004.04.001_BIB139","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00002281-199711000-00008","article-title":"Classifications criteria for the idiopathic inflammatory myopathies","volume":"9","author":"Targoff","year":"1997","journal-title":"Curr Opin Rheumatol"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861904000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861904000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T22:40:13Z","timestamp":1586212813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861904000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":139,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0733861904000313"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2004.04.001","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}